We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Topical cosmetic ingredient — not a dietary supplement
Alpha-Arbutin is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most Alpha-Arbutin studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2004–2025 with a typical study size of 124 participants.
Based on 6 studies · 1 RCT · 154 total participants
Confidence
LowBy outcome
Alpha-Arbutin has an evidence score of 4/10 — emerging evidence based on 6 indexed studies. A topical skin-brightening active applied to the skin for hyperpigmentation and melasma — a cosmetic, not ingested. Alpha-arbutin is a plant-derived glucoside of hydroquinone that competitively inhibits human tyrosinase, the enzyme that makes melanin, and is marketed as a gentler 'hydroquinone-free' brightener. The honest framing: the mechanism is solid and it reliably reduces melanin in cell and skin-model studies, but human clinical evidence is modest — small, pilot-grade trials, usually combined with other actives (kojic acid, sunscreen, lasers), with no large standalone RCT. There's also a chemistry caveat: arbutin can hydrolyse to hydroquinone under heat, UV, or acidic conditions, undercutting the 'safe, hydroquinone-free' claim. These are cosmetic appearance outcomes, not health outcomes. Representative study: PMID 37744793.
The commonly studied dose of Alpha-Arbutin is Topical cosmetic only. Alpha-arbutin is typically used at roughly 1-2% in leave-on serums, applied to areas of hyperpigmentation once or twice daily, usually alongside daily sunscreen and often with other brighteners. There is no oral, injectable, or systemic dose — it is not ingested. This library does not provide an ingestion protocol.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Practical, evidence-based guides that cover Alpha-Arbutin.
Explore: Best supplements for Skin, Hair & Beauty
Last reviewed June 2026 · evidence from 6 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Alpha-Arbutin (topical)
A topical skin-brightening active applied to the skin for hyperpigmentation and melasma — a cosmetic, not ingested. Alpha-arbutin is a plant-derived glucoside of hydroquinone that competitively inhibits human tyrosinase, the enzyme that makes melanin, and is marketed as a gentler 'hydroquinone-free' brightener. The honest framing: the mechanism is solid and it reliably reduces melanin in cell and skin-model studies, but human clinical evidence is modest — small, pilot-grade trials, usually combined with other actives (kojic acid, sunscreen, lasers), with no large standalone RCT. There's also a chemistry caveat: arbutin can hydrolyse to hydroquinone under heat, UV, or acidic conditions, undercutting the 'safe, hydroquinone-free' claim. These are cosmetic appearance outcomes, not health outcomes.
A clear, well-characterized mechanism (competitive human-tyrosinase inhibition, reproducible depigmentation in human skin models), but human efficacy rests on small, pilot-grade, usually combination trials with no large standalone RCT, plus a real chemical-degradation caveat (arbutin can hydrolyse to hydroquinone).
Alpha-arbutin (4-hydroxyphenyl alpha-glucopyranoside) is a glycosylated form of hydroquinone used as a topical skin-lightening active, typically around 1-2% in serums. The alpha-anomer is more stable and a more potent human-tyrosinase inhibitor than the naturally occurring beta-arbutin found in bearberry.
This entry covers TOPICAL cosmetic use — it is not ingested.
Mechanistically the case is strong: alpha-arbutin is a competitive inhibitor of human tyrosinase (Ki ~0.2 mM) and reduced melanin synthesis to ~40% of control in a three-dimensional human skin model, acting by direct enzyme inhibition rather than suppressing tyrosinase gene expression.
The clinical evidence, however, is modest and largely combination-based.
The best standalone trial (Tantanasrigul et al., 2025) was a 30-patient split-face pilot comparing alpha-arbutin 5% + kojic acid 2% against a triple-combination cream: the two did not differ significantly on melanin index or mMASI, and only the triple-combination side showed physician-rated improvement — i.e., arbutin was an alternative, not superior, to standard therapy, with fewer side effects.
A larger open-label study (Gabhane et al., 2025; 124 women) of alpha-arbutin combined with trihydroxybenzoic acid glucoside and sunscreen showed significant melanin (-16.3%) and mMASI (-18.4%) reductions over 90 days, but had no control arm and bundled multiple actives.
A systematic review of antimelanogenic agents positions arbutin among the established cosmetic brighteners whose use is 'limited due to adverse effects and cytotoxic issues.' The mandatory counter-evidence is a chemistry one: an analytical study (Khadivi et al., 2024) showed arbutin in topical formulations decomposes into hydroquinone and p-benzoquinone under temperature stress, UV light, or acidic dilution — all potentially skin-toxic — which weakens the central marketing claim that arbutin is a uniformly safe, hydroquinone-free alternative.
None of this is a health claim: alpha-arbutin is a lawful cosmetic with a sound brightening mechanism but modest, mostly combination-based human evidence and a real stability caveat.
It is listed under Beauty & Appearance so it is discoverable, but is sandboxed out of ingestible-supplement stacks and the schedule optimizer; it carries a cosmetic badge and a topical-only disclaimer.
Alpha-arbutin competitively inhibits human tyrosinase (Ki ~0.2 mM), the rate-limiting enzyme of melanin synthesis, reducing pigment production without changing tyrosinase gene expression. In a 3D human skin model it cut melanin synthesis to about 40% of control — a clear mechanism that translates into a modest clinical effect.
Arbutin is a glucoside of hydroquinone, designed to release activity gradually and gently. The trade-off: under heat, UV, or acidic conditions it can hydrolyse back to hydroquinone (and p-benzoquinone), so a poorly formulated or degraded product is neither as gentle nor as 'hydroquinone-free' as marketed.
Topical cosmetic only. Alpha-arbutin is typically used at roughly 1-2% in leave-on serums, applied to areas of hyperpigmentation once or twice daily, usually alongside daily sunscreen and often with other brighteners. There is no oral, injectable, or systemic dose — it is not ingested. This library does not provide an ingestion protocol.
| Form | Type |
|---|---|
| 🧴Leave-on topical serum (≈1-2% alpha-arbutin) | Recommended |
| 💊Combination brightening serums containing alpha-arbutin | Alternative |
There is no oral or injectable cosmetic form. Alpha-arbutin is a skincare active applied to the skin surface.
Minimum: 8 weeks
Optimal: 12 weeks
Cycling: Not required
Note: Applied to pigmented areas once or twice daily. As a leave-on cosmetic there is no ingestion or meal-timing consideration; daily sunscreen is essential for any pigment goal.
The documented benefit is a modest improvement in the APPEARANCE of hyperpigmentation. Alpha-arbutin is a topical cosmetic ingredient, not an ingested supplement, and it does not treat any disease.
Reduces the appearance of hyperpigmentation and melasma, with the clearest results when combined with other brighteners or sunscreen. Standalone effect is modest.
Usually causes less irritation than hydroquinone or strong acids, which is its main practical appeal. Patch-test as with any active.
No large standalone trial exists; most positive data bundle arbutin with kojic acid, sunscreen, or lasers, so its independent contribution is uncertain.
Under heat, UV, or acidic conditions arbutin can hydrolyse to hydroquinone and p-benzoquinone. Favour stable formulations in good packaging, and don't assume it is entirely hydroquinone-free.
Because arbutin can release hydroquinone, many clinicians prefer better-studied options (e.g. azelaic acid) in pregnancy; discuss with a clinician.
Generally gentle, but patch-test and introduce alongside, not on top of, other strong actives.
Manage expectations — arbutin is a modest, usually adjunct brightener; hydroquinone, azelaic acid, or clinician-guided combinations have stronger evidence, and daily sunscreen is essential.
Often layered with other brighteners/exfoliants, which can increase irritation; introduce gradually. This is a tolerability/formulation consideration, not a systemic drug interaction — it is not ingested.
Tip: Patch-test; reduce frequency or concentration if irritation occurs.
Tip: Discard old/discoloured product; choose stable formulations to limit hydrolysis.
Timing is flexible for Alpha-Arbutin — consistent daily use matters more than the time of day. Alpha-arbutin is a leave-on topical with no meal-timing relationship; pairing with daily sunscreen matters more, since UV drives the pigmentation it targets and can also degrade the molecule.
Alpha-Arbutin is generally well-tolerated and considered safe for most healthy adults at recommended doses. The most commonly reported side effects are mild local irritation or redness, hydroquinone-related sensitivity (from degraded product). Use caution if any of these apply to you: For topical (skin) use only — not for ingestion, not for injection; Known allergy or sensitivity to arbutin or hydroquinone; Application to broken, irritated, or compromised skin until healed.